Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer

British Journal of Radiology

Volumn 85, Issue 1018, 2012, Pages 1415-1419

  Fiorentino, Alba ^a   Caivano, R ^a   Metallo, V ^a   Chiumento, C ^a   Cozzolino, M ^a   Califano, G ^a   Clemente, S ^a   Pedicini, P ^a   Fusco, V ^a  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONE BEAM COMPUTED TOMOGRAPHY; FEMALE; HEAD AND NECK CANCER; HISTOGRAM; HUMAN; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; MALE; ORGAN SIZE; PAROTID GLAND; PROSPECTIVE STUDY; RADIATION DOSE; RETROSPECTIVE STUDY; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; CONE-BEAM COMPUTED TOMOGRAPHY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; ORGAN SPARING TREATMENTS; PAROTID GLAND; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 84866852224     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/30678306     Document Type: Article

References (26)

1. Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, et al. Sparing of submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 2006;78:270-5.
2. Barker JL Jr, Garden AS, Ang KK, O'Daniel JC, Wang H, Court LE, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004;59:960-70. (Pubitemid 38834288)
3. Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, et al. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys 2008;71:1563-71.
4. Han C, Chen YJ, Liu A, Schultheiss TE, Wong JY. Actual dose variation of parotid glands and spinal cord for nasopharyngeal cancer patients during radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1256-62.
5. Rosenthal DI, Chambers MS, Fuller CD, Rebueno NC, Garcia J, Kies MS, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;72:747-55.
6. Robar JL, Day A, Clancey J, Kelly R, Yewondwossen M, Hollenhorst H, et al. Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007;68:1121-30. (Pubitemid 47048570)
7. Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006;64:355-62. (Pubitemid 43083419)
8. Ballivy O, Parker W, Vuong T, Shenouda G, Patrocinio H. Impact of geometric uncertainties on the dose distribution during intensity modulated radiotherapy (IMRT) of head and neck cancer: the need for planning target volume (PTV) and planning organ at risk volume (PRV). Curr Oncol 2006;13:108-15.
9. WuQ, Chi Y, Chen PY, Krauss DJ, Yan D,Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 2009;75:924-32.
10. Ricchetti F, Wu B, McNutt T, Wong J, Forastiere A, Marur S, et al. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011;80:161-8.
11. Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Okumura M, et al. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancer treated with IMRT. Jpn J Clin Oncol 2005;35:375-9. (Pubitemid 41418694)
12. Vásquez Osorio EM, Hoogeman MS, Al-Mamgani A, Teguh DN, Levendag PC, Heijmen BJ. Local anatomical changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correction with dose, studied in detail with non-rigid registration. Int J Radiat Oncol Biol Phys 2008;70:875-82. (Pubitemid 351199733)
13. Kubicek GJ, Machtay M. New advances in high-technology radiotherapy for head and neck cancer. Hematol Oncol Clin North Am 2008;22:1165-80.
14. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51:880-914.
15. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-91. (Pubitemid 44633504)
16. Xing L, Thorndyke B, Schreibmann E, Yang Y, Li TF, Kim GY, et al. Overview of image guided radiation therapy. Med Dosim 2006;31:91-112.
17. Verellen D, Ridder MD, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007;7:949-60. (Pubitemid 350165868)
18. Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, et al. for the Breast Technology Group. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007;82:254-64. (Pubitemid 46341474)
19. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008;9:367-75. (Pubitemid 351411653)
20. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36.
21. Ding GX, Munro P, Pawlowski J, Malcom A, Coffey CW. Reducing radiation exposure to patients from Kv-CBCT imaging. Radiother Oncol 2010;97:585-92.
22. Galvin JM, Ezzell G, Eisbrauch A, Yu C, Butler B, Xiao Y, et al. American Society for Therapeutic Radiology and Oncology; American Association of Physicists in Medicine. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 2004;58:1616-34. (Pubitemid 38438327)
23. Loo H, Fairfoul J, Chakrabarti A, Dean JC, Benson RJ, Jefferies SJ, et al. Tumor shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the tomotherapy HiArtTM System. Clin Oncol 2011;23:40-7.
24. Height R, Khoo V, Lawford C, Cox J, Joon DL, Rolfo A, et al. The dosimetric consequences of anatomic changes in head and neck radiotherapy patients. J Med Imaging Radiat Oncol 2010;54:497-504.
25. Castadot P, Geets X, Lee JA, Gregoire V. Adaptive functional image guided IMRT in pharyngo-laringeal squamous cell carcinoma: is the gain in dose distribution worth the effort? Radiother Oncol 2011;101:343-50.
26. Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 2009;75: 924-32.